Alexander A Fitzpatrick is Chief Legal Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 89,227 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Sep 29, 2023, when has been sold 46,258 shares (Common Stock) at a price of $3.78 per share, resulting in proceeds of $174,855. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 89.2K
0% 3M change
0% 12M change
Total Value Held $0

Alexander A Fitzpatrick Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 29 2023
BUY
Open market or private purchase
$174,855 $3.78 p/Share
46,258 Added 34.14%
89,227 Common Stock
Sep 28 2023
BUY
Open market or private purchase
$144,800 $3.62 p/Share
40,000 Added 48.21%
42,969 Common Stock

Also insider at

EVFM
Evofem Biosciences, Inc. Healthcare
AAF

Alexander A Fitzpatrick

Chief Legal Officer
San Diego, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX